Client News

CEVEC signs agreement with Roche for the use of CEVEC’s ELEVECTA® Technology in gene therapy

HepaRegeniX GmbH to deliver an oral presentation of preclinical results on a inhibition in liver regeneration at The Liver Meeting 2020

CatalYm GmbH: CatalYm raises EUR50 million to advance GDF-15 antibody into clinical trials for checkpoint-inhibitor refractory patients

Verona Pharma plc: Verona Pharma Announces November 2020 Virtual Investor Conference Participation

CENTOGENE GmbH: Fujirebio Europe and CENTOGENE enter partnership to provide rapid and high-quality preventive SARS-CoV-2 antigen testing

APEIRON Biologics AG and Domainex Ltd announce the expansion of their partnership to progress targeted cancer immune therapy drug discovery

InfanDx completes two-year follow-up study AAMBI2 of newborns with suspected perinatal asphyxia

Tacalyx GmbH: Tacalyx Appoints Dr. Klaus Schollmeier as Chairman of the Board

CENTOGENE GmbH: CENTOGENE Opens Walk-In COVID-19 Testing Facility at Berlin Brandenburg Airport

4basebio reports on results of Extraordinary General Meeting 2020